{"id":"NCT01401465","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray","officialTitle":"A Randomized Two Period Two-Way Crossover Study To Evaluate Patient Preference, Satisfaction And Efficacy Of A Nasal Aerosol Versus An Aqueous Nasal Spray Used For The Treatment Of Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2011-07-25","resultsPosted":"2013-04-30","lastUpdate":"2013-04-30"},"enrollment":327,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"ciclesonide","otherNames":[]},{"type":"DRUG","name":"mometasone","otherNames":[]}],"arms":[{"label":"Ciclesonide Nasal Aerosol","type":"EXPERIMENTAL"},{"label":"Mometasone Nasal Spray","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, multicenter, 2-way crossover study in subjects 12 years or older with perennial allergic rhinitis (PAR) to evaluate patient preference, satisfaction and efficacy of ciclesonide nasal aerosol versus mometasone aqueous nasal spray. A novel patient-administered assessment, developed and validated to measure patient satisfaction with and preference of intranasal corticosteroids (INCS) for the treatment of allergic rhinitis (AR), is utilized in this study.","primaryOutcome":{"measure":"Total Preference Composite Score Assessed at the End of the Study. The Total Preference Score is the Standardized Sum of 17 Individual Preference Items","timeFrame":"End of Study - Day 43","effectByArm":[{"arm":"Ciclesonide Versus Mometasone","deltaMin":68.3,"sd":35.2}],"pValues":[{"comp":"OG000","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":21},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":["24169063"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":311},"commonTop":["Application site pain","Headache","Epistaxis"]}}